Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Diseases

Explore clinical trials studying Pancreatic Diseases. Study availability and eligibility vary by location and protocol.

137 public trials 35 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Diseases trial results

Completed

SpyGlass™ Discover Percutaneous

NCT04580940

Conditions
Bile Duct Diseases, Bile Duct Obstruction, Biliary Tract Diseases, +3 more
Locations
  • Virginia Mason Medical Center Seattle, Washington, United States
  • Erasme University Hospital Brussels, Belgium
  • Toronto General Hospital, University Health Network Toronto, Ontario, Canada
  • Evangelisches Krakenhaus Düsseldorf Düsseldorf, Germany
View Trial Details
Completed

A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer

NCT02231723

Conditions
Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +17 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Emory University Winship Cancer Institute Atlanta, Georgia, United States
  • Parkview Research Center Fort Wayne, Indiana, United States
  • Indiana University Health Goshen Center for Cancer Care Goshen, Indiana, United States
View Trial Details
Completed

A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma

NCT02993731

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Ductal, +12 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Clearview Cancer Institute (CCI) Huntsville, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Phoenix, Arizona, United States
View all 267 locations
View Trial Details
Completed

Baby Formula and Health

NCT04559490

Conditions
Digestive System Diseases, Pancreas Disease, Pancreatic Diseases
Locations
  • Clinical Research Center of the University of Rochester Medical Center Rochester, New York, United States
View Trial Details
Completed

Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)

NCT01964430

Conditions
Adenocarcinoma, Antimetabolites, Antineoplastic, Carcinoma, +11 more
Locations
  • Local Institution - 043 Scottsdale, Arizona, United States
  • Mayo Clinic - Arizona Scottsdale, Arizona, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • University of Southern California Los Angeles, California, United States
View all 341 locations
View Trial Details

Related conditions